Latest diabetic neuropathy Stories
RICHMOND, Calif., Jan. 10, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN).
RICHMOND, Calif., Nov. 17, 2010 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
Celebrating Ground-Breaking Alpha Lipoic Acid Discovery Alpha lipoic acid is a remarkable natural substance, with surprisingly diverse and beneficial properties, but diminished by the poor solubility of raw material crystalline alpha lipoic acid powder used in most oral formulations.
BALTIMORE, Sept. 14 /PRNewswire/ -- Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S.
RICHMOND, Calif., July 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
BALTIMORE, July 20 /PRNewswire/ -- Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN).
RICHMOND, Calif., June 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
Neuropathy Association Marks the Week and 15 Years of Service with Lighting to Raise Awareness of Chronic Neurological Disease Affecting 20 Million Americans NEW YORK, May 17 /PRNewswire-USNewswire/ -- For National Neuropathy Week, May 17-21, The Neuropathy Association will join with the Empire State Building to raise neuropathy awareness, recognize National Neuropathy Week, and commemorate the Association's 15th Anniversary.
RICHMOND, Calif., May 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2010 financial results and accomplishments.
Epidemiological data regarding the association of GI symptoms with diabetes are inconsistent, and the reported frequency of upper and lower GI symptoms varies among different ethnic groups/populations.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.